The Geneva Foundation: Clinical Trials

1 trial sponsored by The Geneva Foundation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow The Geneva Foundation: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination HTNV and PUUV DNA Vaccine
Hantaan virus vaccine (HTNV) - Using TriGrid Delivery System (TDS) for Intradermal Delivery (ID), Hantaan virus vaccine (HTNV) - Using TriGrid Delivery System (TDS) for Intramuscular Delivery (IM), Puumala virus vaccine (PUUV) - Using the TriGrid Delivery System (TDS) for Intradermal Delivery (ID) - Hantaan Virus Disease, Puumala Virus
Phase 1CompletedU.S. Army Medical Research and Development Command612019-07-102025-06-26

Conditions studied

Hantavirus Infections (1)

Interventions

tyramine-deoxysorbitol (1)

Countries

United States (1)

Top investigators

Kirsten E Lyke, MD (1)